|
|
||||||||
1 Institut National de la
Santé et de la Recherche Médicale U444, In spontaneously hypertensive rats (SHR),
chronic infusion of clonidine failed to decrease blood pressure and
blood pressure variability. We used nonlinear methods to get a deeper
insight on the effects of clonidine on blood pressure dynamics. For 24 h and 4 wk, clonidine (0.1 mg · kg
recurrence plot; lmax index; Lyapunov exponent; cardiovascular dynamics
IN HUMANS AND IN ANIMALS, clonidine, a centrally acting
antihypertensive agent (19), decreases both blood pressure level and
blood pressure variation assessed by spectral analysis (2, 5, 8, 18).
In contrast, the effects of clonidine on the blood pressure
variability, assessed by the standard deviation (SD), are inconsistent.
Although clonidine reduced the SD of blood pressure in normotensive
rats and hypertensive patients (5, 8), it did not change SD of blood
pressure in hypertensive rats or normotensive volunteers (2, 9, 18).
Moreover, chronic treatment with clonidine failed to decrease blood
pressure level and its SD in conscious spontaneously hypertensive rats (SHRs) (2, 4). The fact that clonidine had no chronic effect on blood
pressure level and on blood pressure variability was surprising. We
suggest that the use of linear indexes, such as mean value, SD, and
spectral method was insufficient to analyze the effect of clonidine on
blood pressure dynamics.
In recent years, it has been argued that the mechanisms regulating
blood pressure are most probably nonlinear (1, 20, 21). Therefore,
nonlinear methods should also be used to analyze blood pressure time
series. Several authors have used nonlinear techniques to analyze heart
rate and blood pressure in healthy conditions and in various
pathologies and have obtained useful results (see, for example, Refs.
1, 14, 15, 20, 26-28).
One marker of nonlinear dynamics that we consider as the most important
is the Lyapunov exponent. The meaning of this index is simple to
explain. Some dynamics have the property of "sensitivity to initial
conditions." Starting from two similar values, the systems may
generate two sequences that quickly (exponentially) diverge one from
the other. The exponent of this divergence is called the Lyapunov
exponent. In this work, we used a simple and intuitive method to
estimate this exponent. Our aim was to explore whether, in chronic
dosing, clonidine has modified the Lyapunov exponent of the blood
pressure dynamics.
Male SHRs (n = 24),
aged 13 wk, and age-matched normotensive Wistar-Kyoto (WKY) rats
(n = 16) (Charles River France, St.
Aubin-les-Elbeuf, France) were used according to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institute of Health (NIH Publication No. 85-23,
revised 1985). The SHRs were randomized into four groups of six rats
each. Groups 1 and
2 (SHRs) were treated with a vehicle
(0.9% NaCl) and 0.1 mg · kg Blood Pressure Recording
![]()
ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References
1 · day
1
sc) was infused by minipumps in the conscious SHRs, and, for comparison, a vehicle was infused in SHRs and in Wistar-Kyoto rats.
Blood pressure was recorded for 30 min before and after treatments. We
used the Lyapunov exponent, approximated by the inverse of the
lmax index
derived from the recurrence plot method, to characterize nonlinear
dynamics. Before treatment,
lmax index of
blood pressure was lower (P < 0.01)
in the SHRs than in the Wistar-Kyoto rats. Clonidine significantly
increased lmax
(P < 0.01) to the level observed in
normotensive rats, at 24 h and up to 4 wk after infusion. We conclude
that clonidine has a significant chronic effect on blood pressure
dynamics, as evidenced by nonlinear methods. Our study also suggests
that the mechanisms governing blood pressure variations are nonlinear.
![]()
INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References
![]()
METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References
1 · day
1
sc clonidine, respectively, for 24 h. Groups
3 and 4 (SHRs) were infused with the vehicle and with 0.1 mg · kg
1 · day
1
sc clonidine, respectively, for 4 wk. Groups
5 and 6 (WKY rats, n = 8 in each group) were
infused with the vehicle for 24 h and 4 wk, respectively. Vehicle and
clonidine infusions were performed via osmotic minipumps implanted
subcutaneously, while animals were under ether anesthesia, in the
ventral region of the abdomen (Alzet models 2ML1 and 2ML4,
total volume 2 ml each, nominal rate 10 and 2.5 µl/h, respectively;
Charles River France, St. Aubin-les-Elbeuf, France).
Acute treatments. At 24 h before the beginning of infusion of vehicle or clonidine, the arterial catheter was implanted as described above, and baseline values of arterial pressure were recorded in conscious, freely moving rats 24 h after surgery. After blood pressure was recorded, the minipumps (Alzet model 2ML1) were implanted while animals were under anesthesia. Another recording of blood pressure was performed in the same rats 24 h later. Because of the life span of intra-arterial catheters, baseline values were recorded only in the sample of rats used in acute treatments.
Chronic treatments. In these experiments, the minipumps (Alzet model 2ML4) were implanted at day 0, and the rats were housed in individual cages for 28 days. At day 27, they were prepared for recording of blood pressure as described above. Blood pressure was recorded 24 h after implantation of intra-arterial catheters.
Beat-to-Beat Blood Pressure
Blood pressure signal was sampled through the digital audio tape recorder by a MacLab system (AD Instruments, London, England). From this blood pressure wave, systolic and diastolic blood pressures were computed. Each 30-min record afforded a times series of 8,000-12,000 beat-to-beat systolic blood pressure and diastolic blood pressure. Blood pressure readings outside the range of 100-300 mmHg systolic and 50-250 mmHg diastolic were considered as artifacts, but <1% of values were in that range. To handle artifacts, a moving window of 200 values was screened along the time series. In each window, we computed the mean-value, m, and SD of systolic blood pressure and diastolic blood pressure. Whenever an artifactual systolic or diastolic blood pressure was encountered, the values of systolic and diastolic blood pressures were replaced by the mean value in the windows.Lyapunov Exponent: The lmax Index of the Recurrence Plot
The direct calculation of the Lyapunov exponent from an experimental time series is complicated and requires very long and stationary series (23). To obtain an approximation of the exponent, we used an index called lmax derived from the method of recurrence plot (3). The method has been applied to several biological data in previous reports and has given interesting results (14, 22, 26, 27).To illustrate the method, Fig. 1A shows a series of 20 systolic blood pressure values, xi (in mmHg), i = 1, 2,..., 20. The recurrence plot looks for repeated sequences in the data. We consider that two blood pressure values are the same if their difference is less than a small number (r), say 2 mmHg. Starting from x1, we are interested to see whether the same value (±2 mmHg) occurs later on in the series (i.e., for some j with j > 1). In Fig. 1A, the same values are found at j = 4, 7, 10, 14, and 18. To mark these recurrences, we plot on a 20 × 20 square the points (1, 4), (1, 7), (1, 10), (1, 14), and (1, 18) (Fig. 1B). Then we start from x2 and plot the recurrent points (2, 8), (2, 11), and (2, 16). Figure 1B shows the recurrent points of the total series. Of particular interest are the diagonals in the figure. One example is the line (1, 7)-(2, 8)-(3, 9). This line means that when a recurrence is found, the two sequences starting from these recurrent points remained close together for several subsequent beats: the trajectory x1-x2-x3 was parallel to the trajectory x7-x8-x9. We recall that the Lyapunov exponent of a dynamic is a measure of the divergence of two trajectories that start from two points close to each other. Therefore, the Lyapunov exponent is inversely related to the lmax index (3). A high Lyapunov exponent, i.e., a short lmax, expresses a chaotic dynamic.
|
To analyze blood pressure data, we embedded the one-dimensional blood
pressure data in a p-dimensional
Euclidean space by using the time-delay reconstruction of Takens (16;
see also Ref. 22). The delay of reconstrution was one beat. With use of
the false neighbors method of Kennel et al. (10), the embedding dimension was taken as P = 10. The
recurrence plot method was applied in dimension
10 by using the Euclidean norm. The cutoff value in the
recurrence plot method in dimension 1,
r1, was generally taken as r1 =
f · SD where
f is a fraction of one
unit or less. In dimension p, we used
r = r1
; this formula gives the diagonal
length of a hypercube of side r1. The SD of
blood pressure was ~4-5 mmHg. Here we used
f = 1. Because systolic
blood pressure was somewhat more dispersed than diastolic blood
pressure, we selected finally, r =
mmHg for systolic blood pressure and
r =
mmHg for
diastolic blood pressure. Each blood pressure series included ~10,000
values. We calculated the
lmax for
nonoverlapping segments of 1,000 consecutive readings and took the mean
values of the
lmax obtained in
the different segments. As suggested by Eckmann et al. (3), we also
plotted the histograms of the density of the recurrences in the
diagonal lines to see if some drift might exist in these segments.
Statistical Analysis
The results are expressed as means ± SD. Comparisons between groups were performed by the nonparametric Mann-Whitney test (11).| |
RESULTS |
|---|
|
|
|---|
The effects of clonidine were similar on systolic and diastolic blood pressures. In the following, the term blood pressure means either of the two pressures.
Effects on Blood Pressure Level and Blood Pressure Variability
As expected before treatment, systolic blood pressure and diastolic blood pressure mean values and their SD (in mmHg) were significantly greater (P < 0.01) in the SHR group (mean systolic: 204 ± 4, mean diastolic: 150 ± 5, SD systolic: 8.6 ± 1.2, SD diastolic: 6.9 ± 0.5) than in the WKY group (mean systolic: 136 ± 9, mean diastolic: 103 ± 7, SD systolic: 5.7 ± 0.9, SD diastolic:5.0 ± 0.8). All these variables were the same in the vehicle-treated SHRs and in the clonidine-treated SHRs.After 24 h of treatment, mean value and SD of blood pressure in the clonidine-treated SHRs were significantly decreased compared with the vehicle-treated SHRs (P < 0.05 and P < 0.01, respectively). However, the level of blood pressure in the clonidine-treated SHRs was still significantly higher (P < 0.01) than in the vehicle-treated WKY rats, whereas the SD of blood pressure in the clonidine-treated SHRs was reduced to the level observed in the vehicle-treated WKY rats (Fig. 2).
|
After 4 wk of infusion, blood pressure in the clonidine-treated SHRs unexpectedly rose and recovered to the level observed in the vehicle-treated SHRs. Similarly, the SD of blood pressure were the same in the clonidine-treated SHRs and in the vehicle-treated SHRs. Thus, in contrast to its acute effects, clonidine in chronic treatments did not change the level and the SD of blood pressure (Fig. 2).
Effects on the lmax Index of the Blood Pressure Dynamics
In the histograms of the density of the recurrences along the diagonal lines, we observed no apparent drift in the observed series of data. Before treatment, the lmax index of blood pressure was significantly lower (P < 0.01) in the SHR group (systolic lmax: 46 ± 7, diastolic lmax: 45 ± 7) than in the WKY group (systolic lmax: 97 ± 22, diastolic lmax: 84 ± 17). This index was the same in the vehicle-treated and in the clonidine-treated SHRs.After 24 h of treatment, the lmax of blood pressure was significantly increased (P < 0.01) in the clonidine-treated SHRs compared with the vehicle-treated SHRs. The index in the clonidine-treated SHRs had joined the level observed in the vehicle-treated WKY rats (Fig. 3).
|
After 4 wk, the lmax index of blood pressure in the clonidine-treated SHRs was still significantly increased (P < 0.01) compared with the vehicle-treated SHRs. This index remained at the same level as in the vehicle-treated WKY rats (Fig. 3).
| |
DISCUSSION |
|---|
|
|
|---|
After 24 h of treatment with clonidine in conscious SHRs, blood pressure level and its SD significantly decreased. These effects are consistent with previously published results (5, 8, 9, 18) and may be interpreted as the consequence of the centrally mediated inhibition of sympathetic tone induced by the drug (19).
In contrast to acute treatments, after 4 wk of infusion, clonidine no longer changed blood pressure level and its SD. The lack of effectiveness of clonidine on blood pressure level may be ascribed to the development of tolerance rather than to a malfunctioning of the micropumps. Indeed, after 4 wk of infusion, flesinoxan, another centrally acting antihypertensive agent (13, 24), significantly reduced blood pressure level in SHRs (2). On the other hand, tolerance also develops to the antihypertensive effects of rilmenidine when it is infused in SHRs (4). Observations of results on the SD of blood pressure were also inconsistent. Whereas clonidine reduced the SD of blood pressure in normotensive rats and hypertensive patients (5, 8), it did not change the SD in hypertensive rats and in normotensive volunteers (2, 9, 18).
We suggest that the absence of chronic effect of, and/or inconsistent results with, clonidine might be caused by the method of analysis. The use of blood pressure level and SD or spectral method might not be instructive enough, and the method was unable to explore the deep impact of clonidine on the blood pressure dynamics. It is clear that if we randomly perturb the initial order of the blood pressure series, then we obtain a new series with the same mean value and the same SD as the initial series. Therefore, mean value and SD cannot account for the temporal structure of the initial series. On the other hand, in the Fourier method, one decomposes the blood pressure signal into a sum of many cosine functions with different amplitudes and phases. However, the spectrum of the series uses only the amplitudes of the cosines and cannot account for a change in the phases of the different cosines. More subtle is the reason why the Fourier method cannot account for a possible sequential nonlinear relationship in the initial series. Theiler et al. (17) have shown that one can random modify a time series without modifying its linear sequential relationship (i.e., its linear autocorrelation coefficients). In the new series, the Fourier spectra are the same as in the initial series. For these reasons, nonlinear methods are needed to explore a possible nonlinear time-dependent relationship in the original data.
In this work, we have used a nonlinear lmax index, obtained by the recurrence plot method, to characterize the dynamic of blood pressure variation before and after treatment with clonidine. The meaning of lmax is simple (see details in the METHODS section). This index is approximately proportional to the inverse of the well-known Lyapunov exponent, which characterizes the dependency of the dynamic on initial conditions.
We have calculated the lmax in dimension 10. This dimension was suggested by the application of the false-neighbors method of Kennel et al. (10) to our observations. This result is in agreement with previous reports analyzing physiological data. Webber and Zbilut (22) used the same dimension to study electromyogram recording. Layne et al. (12), estimating fractal dimension of electroencephalogram data, showed that the fractal dimension was stabilized for an embedding dimension larger than ~10.
Nonlinear methods, in particular the recurrence plot method, have been used in previous reports. It was shown that the new methods could discover some important properties in the time series that were unrevealed by linear methods (14, 22).
It is interesting to notice that, before treatment, the lmax index is shorter in the SHRs than in the WKY rats. This means that the blood pressure dynamic is more sensitive to initial conditions in the hypertensive rats than in the normotensive rats. It has been suggested that physiological dynamics show a large variability in the healthy condition whereas a loss of variability is a sign of some pathology (7). Wagner et al. (20) showed that blood pressure regulation in the intact dog has a positive Lyapunov exponent and a decreased exponent was seen after baroreceptor denervation. Similarly, when analyzing electroencephalogram data of patients suffering from multiple sclerosis, Ganz et al. (6) also observed a decrease of Lyapunov exponent in pathological conditions. We also observed a longer lmax of heart rate variation in patients with diabetes mellitus and dysautonomy compared with control patients without dysautonomy (14). However, in contrast to the above results, Yip et al. (25) observed almost periodic oscillations of tubular pressure in the kidneys of normal rats. The oscillations had more aperiodic character after arterial clipping of one kidney and in SHRs. Results of the present study were in the same direction as those of Yip et al. (25). Therefore, it seems that the question of whether physiological dynamics are more or less "chaotic" in healthy status compared with some disease status cannot be stated in a general manner. The answer depends on the parameter analyzed, the type of pathology, the species, or both.
We have shown that 24 h after dosing, clonidine significantly increased the lmax index of systolic and diastolic blood pressures in the direction of normality, and this effect was maintained until the end of the period of treatment (28 days). One interesting point is the fact that the index, at the 24th h after treatment, and on day 28, reached the level observed in the normotensive rats.
In contrast to
lmax, blood
pressure level and its SD returned to the pretreatment level 28 days
after clonidine infusion. It might be surprising that blood pressure
dynamics in the SHRs before and after 4 wk of clonidine may have
different regulations, as witnessed by two different
lmax
coefficients, and yet have the same mean level and the
same SD. An explanation may be the fact that many factors might act on
mean level, SD, and the sensitivity of blood pressure to initial
conditions. We give an example to illustrate this point. Fig.
4 shows two series generated by the recurrence equation
xn+1 = a
xn
b
x2n, with two coefficients of regulation, a
and b. In this model, coefficient a acts on the sensitivity to initial
conditions and mean values of the time series, while coefficient
b acts solely on the mean level. We
chose a = 3.95, b = 4.45 in series
A and a = 3.86, b = 4.36 in series
B. The two series have almost the same mean values (0.51 and 0.52, respectively) and SD (0.28 and 0.27, respectively), but
they have quite different
lmax indexes:
lmax is equal to
18 in series A, and
lmax is equal to
37 in series B.
|
In conclusion, the present study demonstrates that clonidine has a significant chronic effect on blood pressure dynamics, but this effect can be evidenced only by nonlinear methods. Our study also suggests that the mechanisms governing blood pressure variations are nonlinear, and nonlinear methods should be used in complement to linear methods (mean values, SD, and spectral power). One important point is the relationship between the lmax index and the known physiological mechanisms that govern blood pressure and heart rate variations. More data are needed to document this issue.
| |
FOOTNOTES |
|---|
Address for reprint requests: N. P. Chau, Centre de Bio-informatique, courrier 7113, Université Paris 7, 2 place Jussieu, 75251 Paris Cedex 05, France (E-mail: chau{at}urbb.jussieu.fr).
Received 23 September 1997; accepted in final form 22 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Almog, Y.,
S. Eliash,
O. Oz,
and
S. Akselrod.
Nonlinear analysis of blood pressure signal-Can it detect malfunctions in blood pressure control?
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H396-H403,
1996
2.
Chaouche-Teyara, K.,
P. Lacolley,
P. Challande,
B. Fournier,
S. Laurent,
M. Safar,
and
H. Dabire.
Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats.
J. Cardiovasc. Pharmacol.
30:
241-244,
1997[Medline].
3.
Eckmann, J. P.,
S. O. Kamphorst,
and
D. Ruelle.
Recurrence plot of dynamical systems.
Europhys. Lett.
4:
973-977,
1987.
4.
Eerdmans, P. H. A.,
H. A. J. Struyker-Boudier,
and
J. G. R. de Mey.
Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats.
J. Hypertens.
6:
S348-S349,
1991.
5.
Elghozi, J. L.,
D. Laude,
and
F. Janvier.
Clonidine reduces blood pressure and heart rate oscillations in hypertensive patients.
J. Cardiovasc. Pharmacol.
17:
935-940,
1991[Medline].
6.
Ganz, R. E.,
G. Weibels,
K. H. Stacker,
P. M. Faustmann,
and
C. W. Zimmermann.
The Lyapunov exponent of heart rate dynamics as a sensitive marker of central autonomic organization: an exemplary study of early multiple sclerosis.
Int. J. Neurosci.
71:
29-36,
1993[Medline].
7.
Goldberger, A. L.,
and
J. B. West.
Fractals in physiology and medicine.
Yale J. Biol. Med.
60:
421-435,
1987[Medline].
8.
Grichois, M. L.,
N. Japundzic,
G. A. Head,
and
J. L. Elghozi.
Clonidine reduces blood pressure and heart rate oscillations in the conscious rat.
J. Cardiovasc. Pharmacol.
16:
449-454,
1990[Medline].
9.
Janssen, B. J. A.,
C. M. Tyssen,
and
H. A. J. Struijker-Boudier.
Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats.
J. Cardiovasc. Pharmacol.
17:
494-503,
1991[Medline].
10.
Kennel, M. B.,
R. Brown,
and
H. D. I. Abarbanel.
Determining embedding dimension for a phase-space reconstruction using a geometrical construction.
Physiol. Rev.
45:
3403-3411,
1992.
11.
Kotz, S.,
and
N. L. Johnson.
Encyclopedia of Statistical Sciences. New York: Wiley, 1985, p. 679-683.
12.
Layne, S. P.,
G. Mayer-Kress,
and
J. Holzfuss.
Problem associated with dimensional analysis of electroencephalogram data.
In: Dimensions and Entropies in Chaotic Systems, edited by G. Mayer-Kress. Berlin: Springer-Verlag, 1985, p. 246-256.
13.
McCall, R. B.,
and
M. E. Clement.
Role of serotonin (1A) and serotonin (2) receptors in the central regulation of the cardiovascular system.
Pharmacol. Rev.
46:
231-243,
1994[Medline].
14.
Mestivier, D.,
N. P. Chau,
X. Chanudet,
B. Bauduceau,
and
P. Larroque.
Relationship between diabetic autonomic dysfunction and heart rate variability assessed by recurrence plot.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1094-H1099,
1997
15.
Pincus, S. M.
Approximate entropy as a measure of system complexity.
Proc. Natl. Acad. Sci. USA
88:
2297-2301,
1990
16.
Takens, F.
Detecting strange attractors in turbulence.
In: Dynamical Systems and Turbulence. Lecture Notes in Math 898, edited by D. A. Rand,
and K. S. Young. Berlin: Springer-Verlag, 1981, p. 336-381.
17.
Theiler, J.,
S. Eubank,
A. Longtin,
B. Galdrikian,
J. D. Farmer,
P. G. Drazin,
and
G. P. King.
Testing for nonlinearity in time series: the method of surrogate data.
Physica. D
58:
77-94,
1992.
18.
Tulen, J. H. M.,
F. M. L. Smeets,
A. J. M. Intveld,
H. G. van Steenis,
B. J. M. van de Wetering,
and
P. Moleman.
Cardiovascular variability after clonidine challenge-assessment of dose-dependent temporal effects by means of spectral analysis.
J. Cardiovasc. Pharmacol.
22:
112-119,
1993[Medline].
19.
Van Zwieten, P. A. From
and
to I-1: an overview of sympathetic receptors involved
in blood pressure control targets for drug treatment.
J. Cardiovasc. Pharmacol. 27, Suppl.: S5-S10,
1996.
20.
Wagner, C. D.,
R. Mrowka,
B. Nafz,
and
P. B. Persson.
Complexity and "chaos" in blood pressure after baroreceptor denervation of conscious dogs.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H1760-H1766,
1995
21.
Wagner, C. D.,
B. Nafz,
and
P. B. Persson.
Chaos in blood pressure control.
Cardiovasc. Res.
31:
380-387,
1996[Medline].
22.
Webber, C. K.,
and
J. P. Zbilut.
Dynamical assessment of physiological systems and states using recurrence plot strategies.
J. Appl. Physiol.
76:
965-973,
1994
23.
Wolf, A.,
J. B. Swift,
H. Swinney,
and
J. A. Vastano.
Determining Lypunov exponents from a time series.
Physica. D
16:
285-317,
1985.
24.
Wouters, W.,
J. Hartog,
and
P. Bevan.
Flesinoxan.
Cardiovasc. Drug Rev.
6:
71-83,
1988.
25.
Yip, K. P.,
N. H. Holstein-Rathlou,
and
D. J. Marsh.
Chaos in blood flow control in genetic and renovascular hypertensive rats.
Am. J. Physiol.
261 (Renal Fluid Electrolyte Physiol. 30):
F400-F408,
1991
26.
Zbilut, J. P.,
M. Koebbe,
H. Loeb,
and
G. Mayer-Kress.
Use of recurrence plots in the analysis of heartbeat intervals.
In: Proc. IEEE Computers in Cardiology, edited by A. Muray,
and K. L. Ripley. Los Alamos, CA: IEEE Computer Society, 1991, p. 263-266.
27.
Zbilut, J. P.,
G. Mayer-Kress,
and
K. Geist.
Dimensional analysis of heart rate variability in heart transplant recipients.
Math. Biosci.
90:
49-90,
1988.
28.
Zebrowski, J. J.,
W. Poplawska,
and
R. Baranowski.
Entropy, pattern entropy, and related methods for the analysis of data on the time intervals between heartbeats from 24-h electrocardiograms.
Physiol. Rev.
50:
4188-4205,
1994.
This article has been cited by other articles:
![]() |
F. Beckers, B. Verheyden, and A. E. Aubert Aging and nonlinear heart rate control in a healthy population Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2560 - H2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dabire, D. Mestivier, J. Jarnet, M. E. Safar, and N. P. Chau Quantification of sympathetic and parasympathetic tones by nonlinear indexes in normotensive rats Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1290 - H1297. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |